Epitalon for telomere support

What the evidence says

Evidence tier: Weak anecdotal. Anecdotal reports exist but without strong mechanistic backing for this specific use.

• Telomere-lengthening claims trace to a small Russian study (Khavinson, 2003) showing telomerase activation in cell culture.
• No replicated Western RCT data exists - the evidence base is almost entirely Russian gerontology lab work from the 1990s and 2000s.
• Most-discussed peptide in the longevity biohacker community despite the thin evidence.

Protocol notes

10mg subcutaneous daily for 10 days, repeated every 4-6 months. No human RCT supports a specific protocol.

Always with a sports-medicine doctor, telehealth provider, or specialist sign-off. Self-experimenting on injection schedules without clinical input is the most common way people waste money and get hurt.

What to skip

• Vendors without a Certificate of Analysis (COA). Random gym-bro vendors with no third-party testing. The peptide market has a quality-control problem; the answer is COA per peptide, every time.
• Pre-mixed blends from non-pharmacy sources. Compounding pharmacies that produce pre-mixed combinations with COAs are fine. Random vendor "stack vials" are not.
• Massively over-dosed protocols. More is rarely better with peptides. Receptor saturation is real. Stick to evidence-based dosing.

Where to go next

• Full Epitalon directory entry - status, sourcing, studies, what to skip
• What are peptides - if you skipped the foundation
• How peptides actually work - mechanism in plain English
• The Tier List - which ones to take seriously
• Subscribe to the dispatch

Subscribe to the dispatch

The weekly Protocol One dispatch covers what's moving in peptides, GLP-1s, and longevity protocols. Free. 5-min read. Broken down for normal humans.

-> Subscribe free